Plain-English translation of NCT07599982 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing MODI, a smartphone app designed to help people with diabetes adjust their insulin doses safely and effectively. The app works together with a continuous glucose monitor (a small sensor that tracks your blood sugar throughout the day) to give you personalized insulin guidance. The study will last 13 weeks and aims to make sure the app is safe and helpful for people injecting insulin.
Managing insulin doses can be tricky and stressful — too much or too little can affect your health. This trial exists to see whether the medication can help take the guesswork out of insulin adjustments and make diabetes management easier and safer.
You likely qualify if…
You likely don't qualify if…
You'll start with 2 weeks using your current insulin routine to establish a baseline. Then for 13 weeks, you'll use the MODI app on your smartphone to get personalized insulin dosing guidance, paired with continuous glucose monitoring. You'll log your insulin doses, meals, and daily activities in the study app, which should take just a few minutes each day. The research team will check in with you throughout to make sure everything is working safely.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States